Finance

Lists
OBAT:IDX
Brigit Biofarmaka Teknologi Tbk PT
IDR 234,00
-0,85%
(-2,00) 1D
10 Nov., 15:43:16 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OBAT...
Open
IDR 236
High
IDR 236
Low
IDR 228
Mkt. cap
159,21 mjd
Avg. vol.
474,33 k
Volume
181,00 k
Dividend
3,23%
Quarterly dividend
IDR 2
Ex-dividend date
22 Mei 2026
P/E ratio
8,23
52-wk high
IDR 440
52-wk low
IDR 190
EPS
IDR 28
Shares outstanding
680,38 m
No. of employees
240
Open
IDR 236
High
IDR 236
Low
IDR 228
Mkt. cap
159,21 mjd
Avg. vol.
474,33 k
Volume
181,00 k
Dividend
3,23%
Quarterly dividend
IDR 2
Ex-dividend date
22 Mei 2026
P/E ratio
8,23
52-wk high
IDR 440
52-wk low
IDR 190
EPS
IDR 28
Shares outstanding
680,38 m
No. of employees
240
News stories
From web sources and news partners
About Brigit Biofarmaka Teknologi Tbk PT
CEO-
Employees240
Founded2015
Headquarters-
SectorConsumer Staples
IndustryPersonal care products
Websitebrigit.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
38,18 mjd
45,37 mjd
43,82 mjd
45,18 mjd
Cost of goods sold
18,76 mjd
35,71 mjd
28,17 mjd
28,27 mjd
Cost of revenue
18,76 mjd
35,71 mjd
28,17 mjd
28,27 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,92 mjd
6,42 mjd
10,53 mjd
10,81 mjd
Operating expense
8,67 mjd
7,08 mjd
10,83 mjd
10,70 mjd
Total operating expenses
27,43 mjd
42,80 mjd
39,00 mjd
38,97 mjd
Operating income
10,75 mjd
2,57 mjd
4,83 mjd
6,21 mjd
Other non operating income
-54,54 m
165,04 m
242,73 m
-92,66 m
EBT including unusual items
10,67 mjd
3,27 mjd
4,87 mjd
5,83 mjd
EBT excluding unusual items
10,69 mjd
3,25 mjd
4,87 mjd
5,83 mjd
Income tax expense
4,46 mjd
2,80 mjd
-
1,39 mjd
Effective tax rate
41,86%
85,71%
-
23,88%
Other operating expenses
751,69 m
660,16 m
296,55 m
-105,38 m
Net income
2,38 mjd
2,47 mjd
2,92 mjd
4,40 mjd
Net profit margin
6,22%
5,44%
6,65%
9,75%
Earnings per share
-
-
-
-
Interest and investment income
149,39 m
1,36 mjd
72,42 m
13,58 m
Interest expense
-156,33 m
-1,34 mjd
-266,58 m
-301,05 m
Net interest expenses
-6,94 m
19,56 m
-194,16 m
-287,47 m
Depreciation and amortization charges
-
-
-
-
EBITDA
11,71 mjd
2,63 mjd
5,73 mjd
7,38 mjd
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme